The YUMAB® humanization platform provides two technologies for the humanization of animal-derived antibodies of any source (B-cells, Hybridoma cultures, antibody sequences) by Germline-optimized CDR grafting and Template-driven chain shuffling.

The humanized antibodies can be directly used for further optimization by lead discovery and lead development.